Are CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years agoAre CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years ago
Preclinical Pharmacokinetics: Solving the Problems of Early-Stage Predictive Assays
Understanding the pharmacokinetic profile (PK) of a compound is critical in selecting appropriate drug candidates in preclinical studies. The challenge is to predict the PKs of compounds in humans using early-stage predictive assays in these studies. Innovations in the last...
4 years agoPreclinical Pharmacokinetics: Solving the Problems of Early-Stage Predictive Assays
Understanding the pharmacokinetic profile (PK) of a compound is critical in selecting appropriate drug candidates in preclinical studies. The challenge is to predict the PKs of compounds in humans using early-stage predictive assays in these studies. Innovations in the last...
4 years ago
Emerging therapeutic areas of clinical attention & investment opportunities
Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...
4 years agoEmerging therapeutic areas of clinical attention & investment opportunities
Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...
4 years ago
Weekly News Round-up – 16/4/21
In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...
4 years agoWeekly News Round-up – 16/4/21
In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...
4 years ago
Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years agoEvaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years ago
Innovations in Oncology Today: An Interview with Jessicca Rege
Even aside from the COVID-19 pandemic, 2020 saw a number of innovations in the oncology space, from novel cytokine development to use of NGS to further patient-centric treatment. We spoke to Jessicca Rege, Vice President and Head of Oncology at...
4 years agoInnovations in Oncology Today: An Interview with Jessicca Rege
Even aside from the COVID-19 pandemic, 2020 saw a number of innovations in the oncology space, from novel cytokine development to use of NGS to further patient-centric treatment. We spoke to Jessicca Rege, Vice President and Head of Oncology at...
4 years ago
Evolving Drug Delivery in Parkinson’s Clinical Trials
Effective drug delivery represents a significant challenge in the clinical trial setting, especially for neurological disorders like Parkinson’s. Over the last decade, Parkinson's clinical trials have slowly tried to implement systems to deliver the appropriate therapeutic dose of drugs to...
4 years agoEvolving Drug Delivery in Parkinson’s Clinical Trials
Effective drug delivery represents a significant challenge in the clinical trial setting, especially for neurological disorders like Parkinson’s. Over the last decade, Parkinson's clinical trials have slowly tried to implement systems to deliver the appropriate therapeutic dose of drugs to...
4 years ago
The Challenges of Drug Delivery: An Interview With Prof. Afzal R Mohammed
Conventional drug delivery methods, such as oral and systemic administration, face issues of optimisation, and present certain challenges for physicians. Proventa spoke to Professor Afzal Ur-Rahman Mohammed, Head of Pharmaceutical Sciences at Aston University Pharmacy School, about these challenges, and...
4 years agoThe Challenges of Drug Delivery: An Interview With Prof. Afzal R Mohammed
Conventional drug delivery methods, such as oral and systemic administration, face issues of optimisation, and present certain challenges for physicians. Proventa spoke to Professor Afzal Ur-Rahman Mohammed, Head of Pharmaceutical Sciences at Aston University Pharmacy School, about these challenges, and...
4 years ago
Optimising Paediatric Studies in Clinical Drug Development
Drug development in the world of paediatric medicine is hitting a wall. Without developing new strategies, patient recruitment and retention will continue to plummet and jeopardise lives. Innovative changes to clinical trial design and learning about patient incentives have opened...
4 years agoOptimising Paediatric Studies in Clinical Drug Development
Drug development in the world of paediatric medicine is hitting a wall. Without developing new strategies, patient recruitment and retention will continue to plummet and jeopardise lives. Innovative changes to clinical trial design and learning about patient incentives have opened...
4 years ago
Plant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
4 years agoPlant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
4 years ago